How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity TreatmentInvestors Business Daily • 08/25/23
Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO SaysForbes • 08/25/23
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks SoaringThe Motley Fool • 08/24/23
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors RicherThe Motley Fool • 08/24/23
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find ItThe Motley Fool • 08/23/23
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain PaceZacks Investment Research • 08/21/23
Americans are paying dramatically higher prices for weight-loss drugs like Ozempic, report findsProactive Investors • 08/18/23
Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, NovoInvestors Business Daily • 08/17/23